Hypertension Severity Is Associated With Impaired Cognitive Performance

Imagem de Miniatura
Arquivos
art_MUELA_Hypertension_Severity_Is_Associated_With_Impaired_Cognitive_Performance_2017.PDF (808.06 KB)
Citações na Scopus
66
Tipo de produção
article
Data de publicação
2017
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
WILEY-BLACKWELL
Autores
MACHADO, Michel F.
Citação
JOURNAL OF THE AMERICAN HEART ASSOCIATION, v.6, n.1, article ID e004579, 10p, 2017
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Background-Most evidence of target-organ damage in hypertension (HTN) is related to the kidneys and heart. Cerebrovascular and cognitive impairment are less well studied. Therefore, this study analyzed changes in cognitive function in patients with different stages of hypertension compared to nonhypertensive controls. Methods and Results-In a cross-sectional study, 221 (71 normotensive and 150 hypertensive) patients were compared. Patients with hypertension were divided into 2 stages according to blood pressure (BP) levels or medication use (HTN-1: BP, 140-159/90-99 or use of 1 or 2 antihypertensive drugs; HTN-2: BP, >= 160/100 or use of >= 3 drugs). Three groups were comparatively analyzed: normotension, HTN stage 1, and HTN stage 2. The Mini-Mental State Examination, Montreal Cognitive Assessment, and a validated comprehensive battery of neuropsychological tests that assessed 6 main cognitive domains were used to determine cognitive function. Compared to the normotension and HTN stage-1, the severe HTN group had worse cognitive performance based on MiniMental State Examination (26.8 +/- 2.1 vs 27.4 +/- 2.1 vs 28.0 +/- 2.0; P= 0.004) or Montreal Cognitive Assessment (23.4 +/- 3.7 vs 24.9 +/- 2.8 vs 25.5 +/- 3.2; P< 0.001). On the neuropsychological tests, patients with hypertension had worse performance in language, processing speed, visuospatial abilities, and memory. Age, hypertension stage, and educational level were the best predictors of cognitive impairment in patients with hypertension in different cognitive domains. Conclusions-Cognitive impairment was more frequent in patients with hypertension, and this was related to hypertension severity.
Palavras-chave
cognition, cognitive impairment, high blood pressure, hypertension
URI
https://observatorio.fm.usp.br/handle/OPI/18854
Referências
  1. Antelmi I, 2008, ARQ BRAS CARDIOL, V90, P413, DOI 10.1590/S0066-782X2008000600005
  2. Aprahamian I, 2010, INT PSYCHOGERIATR, V22, P64, DOI 10.1017/S1041610209991141
  3. Axelrod BN, 2001, ARCH CLIN NEUROPSYCH, V16, P293, DOI 10.1016/S0887-6177(00)00048-2
  4. Bischkopf J, 2002, ACTA PSYCHIAT SCAND, V106, P403, DOI 10.1034/j.1600-0447.2002.01417.x
  5. Brucki SMD, 2003, ARQ NEURO-PSIQUIAT, V61, P777, DOI 10.1590/S0004-282X2003000500014
  6. Buffon F, 2006, J NEUROL NEUROSUR PS, V77, P175, DOI 10.1136/jnnp.2005.068726
  7. Carlson MDA, 2009, J PALLIAT MED, V12, P77, DOI 10.1089/jpm.2008.9690
  8. Chaves ML, 2009, J GERIATR PSYCH NEUR, V22, P181, DOI 10.1177/0891988709332942
  9. ELIAS MF, 1993, AM J EPIDEMIOL, V138, P353
  10. Evans DA, 1997, ARCH NEUROL-CHICAGO, V54, P1399
  11. FARMER ME, 1990, J CLIN EPIDEMIOL, V43, P475, DOI 10.1016/0895-4356(90)90136-D
  12. FARMER ME, 1987, AM J EPIDEMIOL, V126, P1103
  13. FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6
  14. Fratiglioni L, 1999, DRUG AGING, V15, P365, DOI 10.2165/00002512-199915050-00004
  15. Frota Norberto Anízio Ferreira, 2011, Dement. neuropsychol., V5, P146, DOI 10.1590/S1980-57642011DN05030002
  16. Garrett Kelly Davis, 2004, Arch Clin Neuropsychol, V19, P745, DOI 10.1016/j.acn.2003.09.008
  17. Gorelick PB, 2011, STROKE, V42, P2672, DOI 10.1161/STR.0b013e3182299496
  18. Guo ZC, 1997, AM J EPIDEMIOL, V145, P1106
  19. Hachinski V, 2006, STROKE, V37, P2220, DOI 10.1161/01.STR.0000237236.88823.47
  20. Harrington F, 2000, HYPERTENSION, V36, P1079
  21. Hugo J, 2014, CLIN GERIATR MED, V30, P421, DOI 10.1016/j.cger.2014.04.001
  22. Iadecola C, 2013, NEURON, V80, P844, DOI 10.1016/j.neuron.2013.10.008
  23. Joffres M, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003423
  24. KALRA L, 1993, J HUM HYPERTENS, V7, P285
  25. Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)17741-1
  26. Kuo HK, 2004, J GERONTOL A-BIOL, V59, P1191
  27. LAUNER LJ, 1995, JAMA-J AM MED ASSOC, V274, P1846, DOI 10.1001/jama.274.23.1846
  28. Leung JLM, 2011, INT PSYCHOGERIATR, V23, P1569, DOI 10.1017/S1041610211000792
  29. Liu H, 2013, J AM GERIATR SOC, V61, P875, DOI 10.1111/jgs.12259
  30. Looi JCL, 1999, NEUROLOGY, V53, P670
  31. Luis CA, 2009, INT J GERIATR PSYCH, V24, P197, DOI 10.1002/gps.2101
  32. Malloy-Diniz LF, 2007, REV BRAS PSIQUIATR, V29, P324, DOI 10.1590/S1516-44462006005000053
  33. Memoria CM, 2013, INT J GERIATR PSYCH, V28, P34, DOI 10.1002/gps.3787
  34. Miotto EC, 2010, REV BRAS PSIQUIATR, V32, P279, DOI 10.1590/S1516-44462010005000006
  35. Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x
  36. Ng A, 2013, SINGAP MED J, V54, P616
  37. O'Sullivan M, 2004, J NEUROL NEUROSUR PS, V75, P441, DOI 10.1136/jnnp.2003.014910
  38. Peters N, 2005, AM J PSYCHIAT, V162, P2078, DOI 10.1176/appi.ajp.162.11.2078
  39. Petersen RC, 1999, ARCH NEUROL-CHICAGO, V56, P303, DOI 10.1001/archneur.56.3.303
  40. Prencipe M, 1996, J NEUROL NEUROSUR PS, V60, P628, DOI 10.1136/jnnp.60.6.628
  41. Prince M, 2013, ALZHEIMERS DEMENT, V9, P63, DOI 10.1016/j.jalz.2012.11.007
  42. ROMAN GC, 1993, NEUROLOGY, V43, P250
  43. ROSEN W G, 1980, Journal of Clinical Neuropsychology, V2, P135, DOI 10.1080/01688638008403788
  44. Scarmeas Nikolaos, 2004, Curr Neurol Neurosci Rep, V4, P374, DOI 10.1007/s11910-004-0084-7
  45. Shin MS, 2006, NAT PROTOC, V1, P892, DOI 10.1038/nprot.2006.115
  46. Skoog I, 1996, LANCET, V347, P1141, DOI 10.1016/S0140-6736(96)90608-X
  47. Sociedade BDH, 2010, ARQ BRAS CARDIOL, V95, P1
  48. Stern Y, 2009, NEUROPSYCHOLOGIA, V47, P2015, DOI 10.1016/j.neuropsychologia.2009.03.004
  49. Strauss E, 2006, COMPENDIUM NEUROPSYC, P655
  50. Tierney MC, 2001, ARCH NEUROL-CHICAGO, V58, P1654, DOI 10.1001/archneur.58.10.1654
  51. Tombaugh TN, 1999, ARCH CLIN NEUROPSYCH, V14, P167, DOI 10.1016/S0887-6177(97)00095-4
  52. Traykov L, 2002, DEMENT GERIATR COGN, V14, P26, DOI 10.1159/000058330
  53. Tsivgoulis G, 2009, NEUROLOGY, V73, P589, DOI 10.1212/WNL.0b013e3181b38969
  54. Waldstein SR, 2005, HYPERTENSION, V45, P374, DOI 10.1161/01.HYP.0000156744.44218.74
  55. Waldstein SR, 2003, CURR DIR PSYCHOL SCI, V12, P9, DOI 10.1111/1467-8721.01212
  56. WILKIE F, 1971, SCIENCE, V172, P959, DOI 10.1126/science.172.3986.959
  57. Zahodne LB, 2011, J INT NEUROPSYCH SOC, V17, P1039, DOI 10.1017/S1355617711001044

Coleções
Artigos e Materiais de Revistas Científicas - FM/MNE
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - HC/InCor
Artigos e Materiais de Revistas Científicas - LIM/15
Artigos e Materiais de Revistas Científicas - LIM/45